Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation

被引：0
|
作者：
Georgios Schoretsanitis
Maxim Kuzin
John M. Kane
Christoph Hiemke
Michael Paulzen
Ekkehard Haen
机构：
[1] Behavioral Health Pavilion,The Zucker Hillside Hospital, Psychiatry Research, Northwell Health
[2] Private Psychiatric Hospital and Academic Teaching Hospital of the University of Zurich,Clienia Schloessli
[3] Zucker School of Medicine at Hofstra/Northwell,Department of Psychiatry and Molecular Medicine
[4] The Feinstein Institute for Medical Research,Center for Psychiatric Neuroscience
[5] University Medical Center of Mainz,Department of Psychiatry and Psychotherapy and Institute of Clinical Chemistry and Laboratory Medicine
[6] Alexianer Hospital Aachen,Department of Psychiatry, Psychotherapy and Psychosomatics
[7] RWTH Aachen University,Department of Psychiatry and Psychotherapy, Clinical Pharmacology
[8] JARA,Department of Pharmacology and Toxicology
[9] Translational Brain Medicine,undefined
[10] University of Regensburg,undefined
[11] University of Regensburg,undefined
来源：
Clinical Pharmacokinetics | 2021年 / 60卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：329 / 335
页数：6
相关论文
共 50 条
  • [21] Acute tyrosine loading in clozapine-treated patients with schizophrenia
    Fuller, MA
    Low, RA
    Steele, VM
    Manuel, MJ
    Strauss, ME
    Konicki, PE
    Jaskiw, GE
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 308 - 309
  • [22] Clozapine-treated patients have low levels of selenium
    Reactions Weekly, 2003, 950 (1) : 4 - 4
  • [23] Agranulocytosis and neutropenia in clozapine-treated patients with schizophrenia in Korea
    Cho, HS
    Kim, CH
    Lee, HS
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 274 - 275
  • [24] Effects of Clozapine on In Vitro Immune Parameters: A Longitudinal Study in Clozapine-Treated Schizophrenic Patients
    Dunja Hinze-Selch
    E Wolfgang Becker
    Gerburg M Stein
    Peter A Berg
    Janet Mullington
    Florian Holsboer
    Thomas Pollmächer
    Neuropsychopharmacology, 1998, 19 : 114 - 122
  • [25] Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels
    Heidi J . Wehring
    Teresa Elsobky
    Joseph P. McEvoy
    Gopal Vyas
    Charles M. Richardson
    Robert P. McMahon
    Bethany A. DiPaula
    Fang Liu
    Kelli Sullivan
    Robert W. Buchanan
    Stephanie Feldman
    Elizabeth M. McMahon
    Deanna L. Kelly
    Psychiatric Quarterly, 2018, 89 : 73 - 80
  • [26] Obsessive-compulsive symptoms in clozapine-treated schizophrenic patients
    Ertugrul, A
    Yagcioglu, AEA
    Eni, N
    Yazici, KM
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2005, 59 (02) : 219 - 222
  • [27] Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management
    Ronaldson, Kathlyn J.
    CNS DRUGS, 2017, 31 (09) : 777 - 795
  • [28] Adjunctive Minocycline in Clozapine-Treated Patients with Schizophrenia: Analyzing the Effects of Minocycline on Clozapine Plasma Levels
    Wehring, Heidi J.
    Elsobky, Teresa
    McEvoy, Joseph P.
    Vyas, Gopal
    Richardson, Charles M.
    McMahon, Robert P.
    DiPaula, Bethany A.
    Liu, Fang
    Sullivan, Kelli
    Buchanan, Robert W.
    Feldman, Stephanie
    McMahon, Elizabeth M.
    Kelly, Deanna L.
    PSYCHIATRIC QUARTERLY, 2018, 89 (01) : 73 - 80
  • [29] Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophrenia
    Fan, X.
    Borba, C. P. C.
    Copeland, P.
    Hayden, D.
    Freudenreich, O.
    Goff, D. C.
    Henderson, D. C.
    ACTA PSYCHIATRICA SCANDINAVICA, 2013, 127 (03) : 217 - 226
  • [30] Risk of neutropenia in a clozapine-treated elderly population
    Guenette, Melanie D.
    Powell, Valerie
    Johnston, Kimberly
    Foussias, George
    Agid, Ofer
    Hahn, Margaret
    Takeuchi, Hiroyoshi
    Remington, Gary
    SCHIZOPHRENIA RESEARCH, 2013, 148 (1-3) : 183 - 185
12345